Latest filing published 03 Jul 2024 for Arrowhead Pharmaceuticals, INC., €221k.
Filing timeline
BuySaleInsider track record
Tracie Oliver: trading record in brief
Tracie Oliver is a declared insider of Arrowhead Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 5 filings; the first trade dates from 4 January 2023 and the latest from 2 July 2024.
Sales make up the whole of the open-market record (3 sales, €512k). Outside the open market, there are 2 share grants. So far in 2024, the count stands at no purchases and 2 sales.
The record was last updated on 3 July 2024 with an open-market sale (€221k) in Arrowhead Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Tracie Oliver
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,394 shares@ US$25.2843.3% of flowCommon StockSEC:0001628280-24-031188:0
- 75,000 shares0Common StockSEC:0001628280-24-000867:0
- 8,925 shares@ US$35.3156.7% of flowCommon StockSEC:0001628280-23-024494:0
- 500 shares0Common StockSEC:0001209191-23-002121:0
4 of 4 declarations
